{"organizations": [], "uuid": "c704e0fa987d81036881252dea367bfb4648c67f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180529.html", "section_title": "Archive News &amp; Video for Tuesday, 29 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/markets-spain-factors/spanish-stocks-factors-to-watch-on-tuesday-idUSL5N1T00NA", "country": "US", "domain_rank": 408, "title": "Spanish stocks - Factors to watch on Tuesday", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-29T13:59:00.000+03:00", "replies_count": 0, "uuid": "c704e0fa987d81036881252dea367bfb4648c67f"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/markets-spain-factors/spanish-stocks-factors-to-watch-on-tuesday-idUSL5N1T00NA", "ord_in_thread": 0, "title": "Spanish stocks - Factors to watch on Tuesday", "locations": [], "entities": {"persons": [{"name": "reut", "sentiment": "neutral"}, {"name": "zepsyre", "sentiment": "none"}, {"name": "bankia bankia", "sentiment": "none"}], "locations": [{"name": "phiia", "sentiment": "none"}, {"name": "uk", "sentiment": "none"}, {"name": "spain", "sentiment": "none"}], "organizations": [{"name": "vidrala vidrala", "sentiment": "none"}, {"name": "independent data monitoring committee", "sentiment": "none"}, {"name": "oryzon oryzon genomics", "sentiment": "none"}, {"name": "mar pharma mar", "sentiment": "none"}, {"name": "goldman sachs", "sentiment": "none"}, {"name": "mhra", "sentiment": "none"}, {"name": "ibex", "sentiment": "none"}, {"name": "credit agricole", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "The following Spanish stocks may be affected by newspaper reports and other factors on Tuesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy:\nVIDRALA Vidrala said on Tuesday it expected double-digit annual growth in earnings per share for the full year 2018.\nPHARMA MAR Pharma Mar says gets recommendation of Independent Data Monitoring Committee (IDMC) to continue Phase III trial with Zepsyre in small-cell lung cancer.\nREE Goldman Sachs raises to “neutral” from “sell”\nORYZON Oryzon Genomics has received approval from UK’s MHRA to conduct Phiia clinical trial with Ory-2001 in patients with Alzheimer.\nBANKIA Bankia says has entered into an agreement with Credit Agricole for creation of a joint venture to jointly operate in consumer finance segment in Spain.\nFor today’s European market outlook double click on.\nFor real-time moves on the Spanish blue-chip index IBEX please double click on\nFor IBEX constituent stocks highlight .IBEX in the command box and press the F3 button on your keyboard\nFor latest news on Spanish stock moves double click\nFor Spanish language market report double click on\nFor latest Eurostocks report please double click on\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-29T13:59:00.000+03:00", "crawled": "2018-05-30T21:09:35.001+03:00", "highlightTitle": ""}